Kidney Transplant Clinical Trials in Pittsburgh, Pennsylvania

4 studies are recruiting for kidney transplant in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Advancing Transplantation Outcomes in Children

    This is a pediatric kidney transplant study comparing the safety and efficacy of an immunosuppressive regimen of belatacept and sirolimus to tacrolimus and Mycophenolate Mofetil (MMF). Two hundred participants will be randomized (1:1) to one of two groups within 24 hours following the transplant pr…

    Stage
    Phase 2
    Ages
    13 to 20
    Site
    UPMC Children's Hospital of Pittsburgh (Site #: 71008), Pittsburgh, Pennsylvania
    Locations
    21 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT06055608 on ClinicalTrials.gov

  2. Empagliflozin Treatment in Kidney Transplant Recipients

    Kidney transplantation improves the health and quality of life for those Veterans with end stage kidney disease (ESKD). While early patient and graft survival are excellent, long-term outcomes continue to be challenging. Patient death with existing kidney graft function occurs in about half of all …

    Stage
    Phase 4
    Ages
    19 and older
    Site
    VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania
    Locations
    5 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT06013865 on ClinicalTrials.gov

  3. Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

    800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/DQ molecular mismatch (mMM) score as a risk-stratifying prognostic biomarker. Six months after transplant the study will identify those who m…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    University of Pittsburgh Medical Center: Transplantation, Pittsburgh, Pennsylvania
    Locations
    15 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT05917522 on ClinicalTrials.gov

  4. An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

    This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh, Pennsylvania
    Locations
    7 in total
    Run by
    Vertex Pharmaceuticals Incorporated

    See if you can join NCT06832410 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.